首页 > 最新文献

Journal of Molecular Biology最新文献

英文 中文
Rising Stars: Adaptation to Environment: From Hormone Signaling to Gene Silencing 冉冉升起的新星:适应环境:从激素信号到基因沉默。
IF 4.5 2区 生物学 Q1 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2026-04-01 Epub Date: 2026-01-29 DOI: 10.1016/j.jmb.2026.169665
Hongwei Guo, Yichuan Wang, Zhenyu Wang, Yuelin Liu
The survival of plants depends on sensitive and efficient systems that perceive and integrate internal hormonal signals with external environmental cues. Deciphering how plants sense and adapt to changing conditions is a fundamental biological question with direct relevance to crop improvement and sustainable agriculture. Hongwei Guo received training in plant molecular genetics and light signaling during his doctoral studies, then turned to how diverse signal pathways converge to coordinate plant development. In his postdoctoral work, he identified EBF1/2-mediated ubiquitin–proteasome turnover of EIN3 as a core mechanism of ethylene signaling. Building on this foundation, his independent research uncovered additional post-transcriptional strategies: proteolytic cleavage and translational repression that fine-tune ethylene responses. He also established an EIN3-centered regulatory network that integrates hormonal and environmental cues to coordinate diverse physiological processes. A forward genetic screen of ethylene-activated plants unexpectedly extended Dr. Guo’s research to siRNA-based regulation. His group discovered a cytoplasmic “dual-safeguard” mechanism in which impairment of mRNA decay triggers the production of coding-transcript–derived siRNAs (ct-siRNAs) that silence endogenous genes. They further showed that stress-induced 22-nt ct-siRNAs amplify silencing to modulate nitrate assimilation and energy balance under abiotic stress. More recently, Dr. Guo’s laboratory has focused on how plant cells sense physical and chemical changes in their surroundings. They identified two extracellular peptide–receptor complexes as apoplastic pH sensors, and demonstrated that cytoplasmic protein DCP5 senses osmotic stress through phase separation to form new stress granules and rapidly reprogram gene expression. Collectively, Dr. Guo’s research connects hormone signaling, gene regulation, and environmental adaptation.
植物的生存依赖于敏感而有效的系统,这些系统能够感知和整合内部激素信号和外部环境信号。破译植物如何感知和适应不断变化的环境是一个与作物改良和可持续农业直接相关的基本生物学问题。郭宏伟博士在攻读植物分子遗传学和光信号转导专业期间,转向研究多种信号通路如何汇聚协调植物发育。在博士后工作中,他发现eb1 /2介导的EIN3泛素蛋白酶体转换是乙烯信号传导的核心机制。在此基础上,他的独立研究发现了额外的转录后策略:蛋白质水解裂解和翻译抑制,这些策略可以微调乙烯反应。他还建立了一个以ein3为中心的调节网络,该网络整合了激素和环境线索,以协调各种生理过程。对乙烯激活植物的前向基因筛选出人意料地将郭博士的研究扩展到基于sirna的调控。他的研究小组发现了一种细胞质“双重保护”机制,在这种机制中,mRNA衰变的损害会引发编码转录衍生的sirna (ct- sirna)的产生,从而使内源性基因沉默。他们进一步表明,在非生物胁迫下,应激诱导的22-nt ct- sirna会放大沉默,从而调节硝酸盐同化和能量平衡。最近,郭博士的实验室专注于研究植物细胞如何感知周围环境的物理和化学变化。他们确定了两种细胞外肽受体复合物作为胞外pH传感器,并证明细胞质蛋白DCP5通过相分离感知渗透胁迫,形成新的胁迫颗粒,并快速重编程基因表达。总的来说,郭博士的研究将激素信号,基因调控和环境适应联系起来。
{"title":"Rising Stars: Adaptation to Environment: From Hormone Signaling to Gene Silencing","authors":"Hongwei Guo,&nbsp;Yichuan Wang,&nbsp;Zhenyu Wang,&nbsp;Yuelin Liu","doi":"10.1016/j.jmb.2026.169665","DOIUrl":"10.1016/j.jmb.2026.169665","url":null,"abstract":"<div><div>The survival of plants depends on sensitive and efficient systems that perceive and integrate internal hormonal signals with external environmental cues. Deciphering how plants sense and adapt to changing conditions is a fundamental biological question with direct relevance to crop improvement and sustainable agriculture. Hongwei Guo received training in plant molecular genetics and light signaling during his doctoral studies, then turned to how diverse signal pathways converge to coordinate plant development. In his postdoctoral work, he identified EBF1/2-mediated ubiquitin–proteasome turnover of EIN3 as a core mechanism of ethylene signaling. Building on this foundation, his independent research uncovered additional post-transcriptional strategies: proteolytic cleavage and translational repression that fine-tune ethylene responses. He also established an EIN3-centered regulatory network that integrates hormonal and environmental cues to coordinate diverse physiological processes. A forward genetic screen of ethylene-activated plants unexpectedly extended Dr. Guo’s research to siRNA-based regulation. His group discovered a cytoplasmic “dual-safeguard” mechanism in which impairment of mRNA decay triggers the production of coding-transcript–derived siRNAs (ct-siRNAs) that silence endogenous genes. They further showed that stress-induced 22-nt ct-siRNAs amplify silencing to modulate nitrate assimilation and energy balance under abiotic stress. More recently, Dr. Guo’s laboratory has focused on how plant cells sense physical and chemical changes in their surroundings. They identified two extracellular peptide–receptor complexes as apoplastic pH sensors, and demonstrated that cytoplasmic protein DCP5 senses osmotic stress through phase separation to form new stress granules and rapidly reprogram gene expression. Collectively, Dr. Guo’s research connects hormone signaling, gene regulation, and environmental adaptation.</div></div>","PeriodicalId":369,"journal":{"name":"Journal of Molecular Biology","volume":"438 7","pages":"Article 169665"},"PeriodicalIF":4.5,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146096690","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Structural Basis for Non-classical WIN Peptides Recognition by WDR5 WDR5识别非经典WIN多肽的结构基础。
IF 4.5 2区 生物学 Q1 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2026-04-01 Epub Date: 2026-01-30 DOI: 10.1016/j.jmb.2026.169666
Yang Yang , Yan Pan , Qingying Wang , Hao Li , Shuting Zhang , Xuefang Sun , Lingyun Xia , Li Xu , Xuemin Chen
WD repeat–containing protein 5 (WDR5) is a core scaffolding component of multiple chromatin-modifying complexes that engages diverse partner proteins through a conserved arginine-binding cavity known as the WDR5-interacting (WIN) site. Dysregulation of WDR5 has been implicated in oncogenesis, making the WIN site a promising therapeutic target. Current inhibitor development has primarily focused on mimicking canonical WIN motif interactions, thereby limiting exploration of alternative recognition modes. Here, we present high-resolution crystal structures of two arginine-containing peptide probes that reveal previously unrecognized binding geometries at the WIN pocket. One peptide adopts an extended linear conformation that bridges both the WIN pocket and the adjacent S7 site. The other binds in a reversed, or “trans-WIN,” orientation, in which a C-terminal arginine anchors the WIN site while an upstream proline residue occupies the S7 pocket. Isothermal titration calorimetry confirmed moderate and specific affinities for both peptides. These findings reveal unexpected conformational adaptability of the WIN site and demonstrate that its recognition capacity extends beyond the canonical mode defined by histone H3 and other partner proteins. Collectively, our results expand the structural repertoire of WIN-site recognition and establish a framework for rational design of next-generation WDR5 inhibitors that exploit multi-site engagement and alternative binding topologies.
WDR5 (WD repeat-containing protein 5, WDR5)是多种染色质修饰复合物的核心支架成分,通过一个被称为WDR5相互作用(WIN)位点的保守精氨酸结合腔与多种伴侣蛋白结合。WDR5的失调与肿瘤发生有关,使WIN位点成为一个有希望的治疗靶点。目前抑制剂的开发主要集中在模仿典型的WIN基序相互作用,从而限制了对其他识别模式的探索。在这里,我们展示了两个含精氨酸肽探针的高分辨率晶体结构,揭示了WIN口袋中以前未被识别的结合几何形状。一个肽采用扩展的线性构象,连接WIN口袋和相邻的S7位点。另一种以相反的或“trans-WIN”方向结合,其中c端精氨酸锚定WIN位点,而上游脯氨酸残基占据S7口袋。等温滴定量热法证实了这两种肽的中等和特异性亲和力。这些发现揭示了WIN位点意想不到的构象适应性,并证明其识别能力超出了由组蛋白H3和其他伙伴蛋白定义的规范模式。总的来说,我们的研究结果扩展了win位点识别的结构库,并为合理设计利用多位点结合和替代结合拓扑的下一代WDR5抑制剂建立了框架。
{"title":"Structural Basis for Non-classical WIN Peptides Recognition by WDR5","authors":"Yang Yang ,&nbsp;Yan Pan ,&nbsp;Qingying Wang ,&nbsp;Hao Li ,&nbsp;Shuting Zhang ,&nbsp;Xuefang Sun ,&nbsp;Lingyun Xia ,&nbsp;Li Xu ,&nbsp;Xuemin Chen","doi":"10.1016/j.jmb.2026.169666","DOIUrl":"10.1016/j.jmb.2026.169666","url":null,"abstract":"<div><div>WD repeat–containing protein 5 (WDR5) is a core scaffolding component of multiple chromatin-modifying complexes that engages diverse partner proteins through a conserved arginine-binding cavity known as the WDR5-interacting (WIN) site. Dysregulation of WDR5 has been implicated in oncogenesis, making the WIN site a promising therapeutic target. Current inhibitor development has primarily focused on mimicking canonical WIN motif interactions, thereby limiting exploration of alternative recognition modes. Here, we present high-resolution crystal structures of two arginine-containing peptide probes that reveal previously unrecognized binding geometries at the WIN pocket. One peptide adopts an extended linear conformation that bridges both the WIN pocket and the adjacent S7 site. The other binds in a reversed, or “<em>trans</em>-WIN,” orientation, in which a C-terminal arginine anchors the WIN site while an upstream proline residue occupies the S7 pocket. Isothermal titration calorimetry confirmed moderate and specific affinities for both peptides. These findings reveal unexpected conformational adaptability of the WIN site and demonstrate that its recognition capacity extends beyond the canonical mode defined by histone H3 and other partner proteins. Collectively, our results expand the structural repertoire of WIN-site recognition and establish a framework for rational design of next-generation WDR5 inhibitors that exploit multi-site engagement and alternative binding topologies.</div></div>","PeriodicalId":369,"journal":{"name":"Journal of Molecular Biology","volume":"438 7","pages":"Article 169666"},"PeriodicalIF":4.5,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146099548","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Anticancer Drug Mitoxantrone Triggers the Formation of Ribosome-enriched Stress Granules Independently of the Classical Translational Control Pathways 抗癌药物米托蒽醌触发核糖体富集应激颗粒的形成,独立于经典的翻译控制途径。
IF 4.5 2区 生物学 Q1 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2026-04-01 Epub Date: 2026-02-02 DOI: 10.1016/j.jmb.2026.169671
Marta Leśniczak-Staszak , Paulina Pietras , Agnieszka Fedoruk-Wyszomirska , Martino Morici , Mateusz Sowiński , Szymon Krawczyk , Małgorzata Andrzejewska , Eliza Wyszko , Michał Nowicki , Paul J. Anderson , Ewelina Gowin , Pavel Ivanov , Daniel N. Wilson , Witold Szaflarski
Mitoxantrone (MIT) is a chemotherapeutic drug widely used for its DNA intercalation and inhibition of topoisomerase. In this work, we show that MIT also affects cytoplasmic RNA–ribosome organization. In human cancer cells, MIT induced stress granules (SGs) that contained large ribosomal subunit proteins, including eL8, together with polyadenylated mRNA. These MIT-induced SGs were different from arsenite-induced SGs: they formed without eIF2α phosphorylation, mTOR inhibition, or 4E-BP1 activity, and they remained stable in the presence of cycloheximide and after drug withdrawal. In vitro assays further demonstrated that MIT promotes ribosome aggregation in a concentration- and salt-dependent manner. Taken together, our results identify a distinct type of ribosome-enriched SGs that form through RNA–ribosome condensation rather than classical translational stress pathways. This mechanism provides a direct example of how a clinically used drug can reorganize cytoplasmic RNA–protein complexes, with possible consequences for mRNA regulation, cancer therapy, and neurodegenerative disease.
米托蒽醌(Mitoxantrone, MIT)是一种广泛应用于DNA嵌入和抑制拓扑异构酶的化疗药物。在这项工作中,我们表明MIT也影响细胞质rna -核糖体组织。在人类癌细胞中,MIT诱导的应激颗粒(SGs)含有大型核糖体亚基蛋白,包括eL8,以及聚腺苷化的mRNA。这些mit诱导的SGs与亚砷酸盐诱导的SGs不同:它们形成时没有eIF2α磷酸化、mTOR抑制或4E-BP1活性,并且在环己亚胺存在和停药后保持稳定。体外实验进一步证明MIT以浓度和盐依赖的方式促进核糖体聚集。综上所述,我们的研究结果确定了一种独特类型的富含核糖体的SGs,它通过rna -核糖体凝聚而不是经典的翻译应激途径形成。这一机制提供了一个直接的例子,说明临床使用的药物如何重组细胞质rna -蛋白复合物,并可能对mRNA调节、癌症治疗和神经退行性疾病产生影响。
{"title":"The Anticancer Drug Mitoxantrone Triggers the Formation of Ribosome-enriched Stress Granules Independently of the Classical Translational Control Pathways","authors":"Marta Leśniczak-Staszak ,&nbsp;Paulina Pietras ,&nbsp;Agnieszka Fedoruk-Wyszomirska ,&nbsp;Martino Morici ,&nbsp;Mateusz Sowiński ,&nbsp;Szymon Krawczyk ,&nbsp;Małgorzata Andrzejewska ,&nbsp;Eliza Wyszko ,&nbsp;Michał Nowicki ,&nbsp;Paul J. Anderson ,&nbsp;Ewelina Gowin ,&nbsp;Pavel Ivanov ,&nbsp;Daniel N. Wilson ,&nbsp;Witold Szaflarski","doi":"10.1016/j.jmb.2026.169671","DOIUrl":"10.1016/j.jmb.2026.169671","url":null,"abstract":"<div><div>Mitoxantrone (MIT) is a chemotherapeutic drug widely used for its DNA intercalation and inhibition of topoisomerase. In this work, we show that MIT also affects cytoplasmic RNA–ribosome organization. In human cancer cells, MIT induced stress granules (SGs) that contained large ribosomal subunit proteins, including eL8, together with polyadenylated mRNA. These MIT-induced SGs were different from arsenite-induced SGs: they formed without eIF2α phosphorylation, mTOR inhibition, or 4E-BP1 activity, and they remained stable in the presence of cycloheximide and after drug withdrawal. In vitro assays further demonstrated that MIT promotes ribosome aggregation in a concentration- and salt-dependent manner. Taken together, our results identify a distinct type of ribosome-enriched SGs that form through RNA–ribosome condensation rather than classical translational stress pathways. This mechanism provides a direct example of how a clinically used drug can reorganize cytoplasmic RNA–protein complexes, with possible consequences for mRNA regulation, cancer therapy, and neurodegenerative disease.</div></div>","PeriodicalId":369,"journal":{"name":"Journal of Molecular Biology","volume":"438 7","pages":"Article 169671"},"PeriodicalIF":4.5,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146117274","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rising Star: Combining Bioinformatics and Experimental Biology to Decoding Non-coding RNAs and RNA Modifications 新星:结合生物信息学和实验生物学解码非编码RNA和RNA修饰。
IF 4.5 2区 生物学 Q1 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2026-04-01 Epub Date: 2026-02-09 DOI: 10.1016/j.jmb.2026.169684
Xiu-Jie Wang
Xiu-Jie Wang studied biochemistry as a master student at Hong Kong University of Sciences and Technology, and obtained her PhD degree in bioinformatics from The Rockefeller University, then joint Institute of Genetics and Developmental Biology, Chinese Academy of Sciences to establish her own research group. The major research focus of Xiu-Jie Wang’s group is to identify functional non-coding RNAs, especially microRNAs, through the combination of bioinformatics and experimental approaches. They found many microRNAs involving in essential physiological processes in plants, virus, and mouse embryonic stem cells, and uncovered a novel function of microRNAs in regulating m6A RNA modification. These findings subsequently led them to extend their research towards m6A regulation and its role in long-term memory formation. Xiu-Jie Wang’s group also developed several bioinformatics tools and databases, which have served as useful resources for the research community.
王秀洁在香港科技大学攻读生物化学硕士学位后,先后在美国洛克菲勒大学和中国科学院遗传与发育生物学联合研究所获得生物信息学博士学位,并组建了自己的研究小组。王秀杰课组的主要研究重点是通过生物信息学和实验相结合的方法,识别功能性非编码rna,特别是microrna。他们发现许多microrna参与植物、病毒和小鼠胚胎干细胞的基本生理过程,并揭示了microrna在调节m6A RNA修饰方面的新功能。这些发现随后引导他们将研究扩展到m6A调节及其在长期记忆形成中的作用。王秀杰的团队还开发了几个生物信息学工具和数据库,为研究界提供了有用的资源。
{"title":"Rising Star: Combining Bioinformatics and Experimental Biology to Decoding Non-coding RNAs and RNA Modifications","authors":"Xiu-Jie Wang","doi":"10.1016/j.jmb.2026.169684","DOIUrl":"10.1016/j.jmb.2026.169684","url":null,"abstract":"<div><div>Xiu-Jie Wang studied biochemistry as a master student at Hong Kong University of Sciences and Technology, and obtained her PhD degree in bioinformatics from The Rockefeller University, then joint Institute of Genetics and Developmental Biology, Chinese Academy of Sciences to establish her own research group. The major research focus of Xiu-Jie Wang’s group is to identify functional non-coding RNAs, especially microRNAs, through the combination of bioinformatics and experimental approaches. They found many microRNAs involving in essential physiological processes in plants, virus, and mouse embryonic stem cells, and uncovered a novel function of microRNAs in regulating m<sup>6</sup>A RNA modification. These findings subsequently led them to extend their research towards m<sup>6</sup>A regulation and its role in long-term memory formation. Xiu-Jie Wang’s group also developed several bioinformatics tools and databases, which have served as useful resources for the research community.</div></div>","PeriodicalId":369,"journal":{"name":"Journal of Molecular Biology","volume":"438 7","pages":"Article 169684"},"PeriodicalIF":4.5,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146163266","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Oligomerization-Dependent Regulation of LrhA Controls Bacterial Flagellar Biosynthesis 寡聚化依赖性调控LrhA控制细菌鞭毛生物合成。
IF 4.5 2区 生物学 Q1 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2026-04-01 Epub Date: 2026-02-06 DOI: 10.1016/j.jmb.2026.169682
Baichun Niu, Masahide Kikkawa, Xuguang Jiang
LysR-type transcriptional regulators (LTTRs) are a diverse family of proteins that regulate various cellular processes, including motility in bacteria. In Escherichia coli, the LTTR LrhA represses flagellar biosynthesis by inhibiting the flhDC operon. However, the structural basis underlying this regulation has remained unclear. Here, we determined both a high-resolution crystal structure and a cryo-EM reconstruction of LrhA, revealing a predominant and stable tetrameric organization with pronounced structural variability in its effector-binding region. Structural and biochemical analyses demonstrate that mutations in these variable regions perturb the oligomeric equilibrium of LrhA, shifting the balance between tetrameric and dimeric species. This shift correlates with enhanced DNA binding affinity and stronger repression of the flhDC promoter. While ligand binding may similarly modulate LrhA activity, our data primarily support a model in which alterations in oligomeric state mediated by the variable regions regulate LrhA function. Together, these findings provide a structural framework for understanding how LrhA controls bacterial motility and offer broader insights into oligomerization-based regulation within the LTTR family.
lysr型转录调节因子(LTTRs)是一个不同的蛋白质家族,调节各种细胞过程,包括细菌的运动。在大肠杆菌中,LTTR LrhA通过抑制flhDC操纵子抑制鞭毛的生物合成。然而,这一规定背后的结构基础仍不清楚。在这里,我们确定了LrhA的高分辨率晶体结构和低温电镜重建,揭示了一个主要和稳定的四聚体组织,其效应结合区具有明显的结构变异性。结构和生化分析表明,这些可变区域的突变扰乱了LrhA的寡聚平衡,改变了四聚体和二聚体物种之间的平衡。这种转变与增强的DNA结合亲和力和对flhDC启动子的更强抑制有关。虽然配体结合可能类似地调节LrhA活性,但我们的数据主要支持一个模型,即可变区域介导的寡聚物状态的改变调节LrhA功能。总之,这些发现为理解LrhA如何控制细菌运动提供了一个结构框架,并为LTTR家族中基于寡聚化的调控提供了更广泛的见解。
{"title":"Oligomerization-Dependent Regulation of LrhA Controls Bacterial Flagellar Biosynthesis","authors":"Baichun Niu,&nbsp;Masahide Kikkawa,&nbsp;Xuguang Jiang","doi":"10.1016/j.jmb.2026.169682","DOIUrl":"10.1016/j.jmb.2026.169682","url":null,"abstract":"<div><div>LysR-type transcriptional regulators (LTTRs) are a diverse family of proteins that regulate various cellular processes, including motility in bacteria. In <em>Escherichia coli</em>, the LTTR LrhA represses flagellar biosynthesis by inhibiting the <em>flhDC</em> operon. However, the structural basis underlying this regulation has remained unclear. Here, we determined both a high-resolution crystal structure and a cryo-EM reconstruction of LrhA, revealing a predominant and stable tetrameric organization with pronounced structural variability in its effector-binding region. Structural and biochemical analyses demonstrate that mutations in these variable regions perturb the oligomeric equilibrium of LrhA, shifting the balance between tetrameric and dimeric species. This shift correlates with enhanced DNA binding affinity and stronger repression of the <em>flhDC</em> promoter. While ligand binding may similarly modulate LrhA activity, our data primarily support a model in which alterations in oligomeric state mediated by the variable regions regulate LrhA function. Together, these findings provide a structural framework for understanding how LrhA controls bacterial motility and offer broader insights into oligomerization-based regulation within the LTTR family.</div></div>","PeriodicalId":369,"journal":{"name":"Journal of Molecular Biology","volume":"438 7","pages":"Article 169682"},"PeriodicalIF":4.5,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146140736","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rising Stars: In vivo Monitoring of Neurochemical Dynamics by Genetically Encoded Neuromodulator Sensors 后起之秀:通过基因编码的神经调节传感器在体内监测神经化学动力学。
IF 4.5 2区 生物学 Q1 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2026-04-01 Epub Date: 2026-01-30 DOI: 10.1016/j.jmb.2026.169669
Shengwei Fu , Yulong Li
Dr. Yulong Li received his undergraduate education in biophysics and physiology at Peking University, and subsequently completed his Ph.D. training under the mentorship of Dr. George J. Augustine at Duke University, where he investigated fundamental mechanisms of synaptic transmission. He then pursued postdoctoral research in the laboratory of Dr. Richard W. Tsien at Stanford University, where he began developing genetically encoded indicators for applications in neuroscience.
Since 2012, Dr. Yulong Li established his lab at Peking University. His research has been at the forefront of developing the genetically encoded fluorescent sensors for neurotransmitters and neuromodulators, which have emerged as powerful tools for real-time monitoring of the dynamic changes of these molecules with high sensitivity, selectivity, spatiotemporal resolution, and minimal invasiveness in vivo. This article provides a comprehensive overview of the design strategies and key progress in this rapid evolving field, emphasizing how these tools have transformed the study of neuromodulation.
李玉龙博士在北京大学获得生物物理学和生理学学士学位,随后在杜克大学乔治·奥古斯丁博士的指导下完成了博士学位,在那里他研究了突触传递的基本机制。随后,他在斯坦福大学(Stanford University)钱存训(Richard W. Tsien)博士的实验室进行博士后研究,在那里他开始开发用于神经科学的基因编码指示器。2012年起,李玉龙博士在北京大学成立实验室。他的研究一直处于开发神经递质和神经调节剂基因编码荧光传感器的前沿,这些传感器已成为实时监测这些分子动态变化的强大工具,具有高灵敏度,选择性,时空分辨率和最小的体内侵入性。本文全面概述了这一快速发展领域的设计策略和关键进展,强调了这些工具如何改变了神经调节的研究。
{"title":"Rising Stars: In vivo Monitoring of Neurochemical Dynamics by Genetically Encoded Neuromodulator Sensors","authors":"Shengwei Fu ,&nbsp;Yulong Li","doi":"10.1016/j.jmb.2026.169669","DOIUrl":"10.1016/j.jmb.2026.169669","url":null,"abstract":"<div><div>Dr. Yulong Li received his undergraduate education in biophysics and physiology at Peking University, and subsequently completed his Ph.D. training under the mentorship of Dr. George J. Augustine at Duke University, where he investigated fundamental mechanisms of synaptic transmission. He then pursued postdoctoral research in the laboratory of Dr. Richard W. Tsien at Stanford University, where he began developing genetically encoded indicators for applications in neuroscience.</div><div>Since 2012, Dr. Yulong Li established his lab at Peking University. His research has been at the forefront of developing the genetically encoded fluorescent sensors for neurotransmitters and neuromodulators, which have emerged as powerful tools for real-time monitoring of the dynamic changes of these molecules with high sensitivity, selectivity, spatiotemporal resolution, and minimal invasiveness <em>in vivo</em>. This article provides a comprehensive overview of the design strategies and key progress in this rapid evolving field, emphasizing how these tools have transformed the study of neuromodulation.</div></div>","PeriodicalId":369,"journal":{"name":"Journal of Molecular Biology","volume":"438 7","pages":"Article 169669"},"PeriodicalIF":4.5,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146099499","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rising Stars: Molecular Mechanisms of Ligand Recognition and Functional Modulation of GPCRs 新兴之星:gpcr配体识别和功能调节的分子机制。
IF 4.5 2区 生物学 Q1 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2026-04-01 Epub Date: 2026-02-05 DOI: 10.1016/j.jmb.2026.169674
Shuo Han , Qiuxiang Tan , Shuling Lin , Kun Chen , Maozhou He , Qiang Zhao , Beili Wu
In response to a variety of signals outside of cells, G protein-coupled receptors (GPCRs) play essential roles in cell signal transduction by relaying the extracellular signals to the intracellular side through various signaling mechanisms, which govern diverse physiological and pathological processes. These receptors are involved in many diseases and comprise the largest drug target family. However, the molecular mechanisms underlying the GPCR signal transduction are poorly understood, which hinders the drug discovery with only a small portion of receptors having drugs marketed. Over the past decade, our laboratory has been focused on the ligand recognition and functional modulation mechanisms of different GPCRs, aiming for better understanding of the physiology and pathology of this receptor superfamily and new clues to carry out drug development. Through extensive structural and functional studies, we uncovered diverse interaction patterns of GPCRs in recognizing various ligands, including small molecules, peptides, and proteins. These molecular details not only reveal key factors that define ligand selectivity and receptor specificity, but also provide insights into allosteric modulation, ligand promiscuity, and intrinsic activation. Our knowledge about the GPCR modulations were further extended by investigating the conformational rearrangements and dynamics of GPCRs upon activation and coupling to downstream signaling transducers. With different molecular architectures, different receptors exhibit distinct patterns in regulating their activities and abilities to stimulate various signaling pathways, which are key for understanding biased signaling. These findings demonstrate the diversity and complexity of GPCR signaling and would enable development of novel drugs with improved efficacy and reduced side effects.
G蛋白偶联受体(G protein-coupled receptor, gpcr)响应细胞外的多种信号,通过多种信号传导机制将细胞外信号传递到细胞内,在细胞信号转导中发挥重要作用,控制着多种生理病理过程。这些受体与许多疾病有关,构成了最大的药物靶点家族。然而,人们对GPCR信号转导的分子机制知之甚少,这阻碍了药物的发现,只有一小部分受体有药物上市。在过去的十年中,我们的实验室一直致力于研究不同gpcr的配体识别和功能调节机制,旨在更好地了解该受体超家族的生理病理,并为开展药物开发提供新的线索。通过广泛的结构和功能研究,我们发现了gpcr在识别各种配体(包括小分子、肽和蛋白质)方面的多种相互作用模式。这些分子细节不仅揭示了确定配体选择性和受体特异性的关键因素,而且还提供了对变构调节、配体混杂和内在激活的见解。通过研究GPCR在激活和与下游信号转导耦合时的构象重排和动力学,我们进一步扩展了对GPCR调节的了解。由于不同的分子结构,不同的受体在调节其活动和刺激各种信号通路的能力方面表现出不同的模式,这是理解偏倚信号传导的关键。这些发现证明了GPCR信号的多样性和复杂性,并将有助于开发具有更高疗效和更少副作用的新药。
{"title":"Rising Stars: Molecular Mechanisms of Ligand Recognition and Functional Modulation of GPCRs","authors":"Shuo Han ,&nbsp;Qiuxiang Tan ,&nbsp;Shuling Lin ,&nbsp;Kun Chen ,&nbsp;Maozhou He ,&nbsp;Qiang Zhao ,&nbsp;Beili Wu","doi":"10.1016/j.jmb.2026.169674","DOIUrl":"10.1016/j.jmb.2026.169674","url":null,"abstract":"<div><div>In response to a variety of signals outside of cells, G protein-coupled receptors (GPCRs) play essential roles in cell signal transduction by relaying the extracellular signals to the intracellular side through various signaling mechanisms, which govern diverse physiological and pathological processes. These receptors are involved in many diseases and comprise the largest drug target family. However, the molecular mechanisms underlying the GPCR signal transduction are poorly understood, which hinders the drug discovery with only a small portion of receptors having drugs marketed. Over the past decade, our laboratory has been focused on the ligand recognition and functional modulation mechanisms of different GPCRs, aiming for better understanding of the physiology and pathology of this receptor superfamily and new clues to carry out drug development. Through extensive structural and functional studies, we uncovered diverse interaction patterns of GPCRs in recognizing various ligands, including small molecules, peptides, and proteins. These molecular details not only reveal key factors that define ligand selectivity and receptor specificity, but also provide insights into allosteric modulation, ligand promiscuity, and intrinsic activation. Our knowledge about the GPCR modulations were further extended by investigating the conformational rearrangements and dynamics of GPCRs upon activation and coupling to downstream signaling transducers. With different molecular architectures, different receptors exhibit distinct patterns in regulating their activities and abilities to stimulate various signaling pathways, which are key for understanding biased signaling. These findings demonstrate the diversity and complexity of GPCR signaling and would enable development of novel drugs with improved efficacy and reduced side effects.</div></div>","PeriodicalId":369,"journal":{"name":"Journal of Molecular Biology","volume":"438 7","pages":"Article 169674"},"PeriodicalIF":4.5,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146130784","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rising Star: Single Cell Omics Technologies: When Whole Omics Analysis Meets Single Cell Resolution 新星:单细胞组学技术:当全组学分析满足单细胞分辨率时。
IF 4.5 2区 生物学 Q1 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2026-04-01 Epub Date: 2026-01-30 DOI: 10.1016/j.jmb.2026.169670
Fuchou Tang
I got my PhD degree under the supervision of Prof. Kegang Shang in 2003. And I did my postdoc research in Azim Surani’s lab. Then I set up my own lab in Biomedical Pioneering Innovation Center at Peking University in 2010. My research has focused on developing single-cell omics sequencing technologies and employing these powerful tools to dissect the gene regulation networks in human germline cell development under both physiological and pathological conditions. My lab systematically developed a serial of single-cell omics sequencing technologies, including the first single-cell DNA methylome sequencing technology in 2013, which was considered to pioneer the single-cell epigenome field. In recent years, my lab has focused on developing single-cell omics long-read sequencing technologies based on single-molecule sequencing platforms, which can reveal critical features of the repetitive elements. The repetitive elements are considered as ‘dark matter’, which account for over half of our genome and play important roles for both normal development and numerous diseases. The research in my lab revealed critical features of the epigenetic reprogramming of human germline cells, deepening our understanding of these cells, which are fundamental to the transgenerational immortality of the human species.
我于2003年在尚克刚教授的指导下获得博士学位。我在阿齐姆·苏拉尼的实验室做博士后研究。2010年,我在北京大学生物医学创新中心成立了自己的实验室。我的研究重点是开发单细胞组学测序技术,并利用这些强大的工具来解剖生理和病理条件下人类生殖细胞发育的基因调控网络。我的实验室系统地开发了一系列单细胞组学测序技术,包括2013年第一个单细胞DNA甲基组测序技术,被认为是单细胞表观基因组领域的先驱。近年来,我的实验室致力于开发基于单分子测序平台的单细胞组学长读测序技术,该技术可以揭示重复元件的关键特征。重复元素被认为是“暗物质”,占我们基因组的一半以上,对正常发育和许多疾病都起着重要作用。我实验室的研究揭示了人类生殖细胞表观遗传重编程的关键特征,加深了我们对这些细胞的理解,这些细胞是人类物种跨代不朽的基础。
{"title":"Rising Star: Single Cell Omics Technologies: When Whole Omics Analysis Meets Single Cell Resolution","authors":"Fuchou Tang","doi":"10.1016/j.jmb.2026.169670","DOIUrl":"10.1016/j.jmb.2026.169670","url":null,"abstract":"<div><div>I got my PhD degree under the supervision of Prof. Kegang Shang in 2003. And I did my postdoc research in Azim Surani’s lab. Then I set up my own lab in Biomedical Pioneering Innovation Center at Peking University in 2010. My research has focused on developing single-cell omics sequencing technologies and employing these powerful tools to dissect the gene regulation networks in human germline cell development under both physiological and pathological conditions. My lab systematically developed a serial of single-cell omics sequencing technologies, including the first single-cell DNA methylome sequencing technology in 2013, which was considered to pioneer the single-cell epigenome field. In recent years, my lab has focused on developing single-cell omics long-read sequencing technologies based on single-molecule sequencing platforms, which can reveal critical features of the repetitive elements. The repetitive elements are considered as ‘dark matter’, which account for over half of our genome and play important roles for both normal development and numerous diseases. The research in my lab revealed critical features of the epigenetic reprogramming of human germline cells, deepening our understanding of these cells, which are fundamental to the transgenerational immortality of the human species.</div></div>","PeriodicalId":369,"journal":{"name":"Journal of Molecular Biology","volume":"438 7","pages":"Article 169670"},"PeriodicalIF":4.5,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146099733","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rising Star: Exploring Weak Biomolecular Interactions: My Steady and Evolving Journey 后起之秀:探索弱生物分子相互作用:我的稳定和不断发展的旅程。
IF 4.5 2区 生物学 Q1 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2026-04-01 Epub Date: 2026-02-06 DOI: 10.1016/j.jmb.2026.169680
Pilong Li
This manuscript reflects the early stages of my ongoing journey into weak biomolecular interactions, beginning with my study of Vav1, a guanine nucleotide exchange factor. In this initial work, I uncovered how weak intramolecular interactions regulate protein activation, providing critical insights into their role in cellular processes like signal transduction. However, my understanding of weak interactions took an unexpected turn during research on the Nck/NWASP complex, when we serendipitously discovered that weak, multivalent interactions drive liquid–liquid phase separation (LLPS), a process essential for cellular organization. This unanticipated finding led to the development of the CoPIC platform, which enables high-throughput detection of weak interactions within living cells. Though the studies on Vav1 and LLPS are independent, both underscore the profound role of weak interactions in regulating cellular dynamics. This ongoing journey continues to challenge and deepen my understanding of how weak interactions orchestrate the complexity of biological systems. This personal trajectory exemplifies how pursuing seemingly focused mechanistic questions can unexpectedly reveal broader principles—here, that weak interactions are not peripheral but central architects of cellular complexity and adaptability.
这篇手稿反映了我正在进行的弱生物分子相互作用之旅的早期阶段,从我对Vav1(一种鸟嘌呤核苷酸交换因子)的研究开始。在这项初步工作中,我揭示了弱分子内相互作用如何调节蛋白质激活,为它们在信号转导等细胞过程中的作用提供了重要的见解。然而,在研究Nck/NWASP复合物时,我对弱相互作用的理解发生了意想不到的转变,当时我们偶然发现弱的多价相互作用驱动液-液相分离(LLPS),这是细胞组织所必需的过程。这一意想不到的发现导致了CoPIC平台的发展,该平台能够高通量检测活细胞内的弱相互作用。尽管Vav1和LLPS的研究是独立的,但它们都强调了弱相互作用在调节细胞动力学中的重要作用。这个正在进行的旅程继续挑战并加深了我对弱相互作用如何协调生物系统复杂性的理解。这一个人轨迹说明,如何追求看似集中的机械问题,却意外地揭示出更广泛的原理——这里,弱相互作用不是细胞复杂性和适应性的外围结构,而是核心结构。
{"title":"Rising Star: Exploring Weak Biomolecular Interactions: My Steady and Evolving Journey","authors":"Pilong Li","doi":"10.1016/j.jmb.2026.169680","DOIUrl":"10.1016/j.jmb.2026.169680","url":null,"abstract":"<div><div>This manuscript reflects the early stages of my ongoing journey into weak biomolecular interactions, beginning with my study of Vav1, a guanine nucleotide exchange factor. In this initial work, I uncovered how weak intramolecular interactions regulate protein activation, providing critical insights into their role in cellular processes like signal transduction. However, my understanding of weak interactions took an unexpected turn during research on the Nck/NWASP complex, when we serendipitously discovered that weak, multivalent interactions drive liquid–liquid phase separation (LLPS), a process essential for cellular organization. This unanticipated finding led to the development of the CoPIC platform, which enables high-throughput detection of weak interactions within living cells. Though the studies on Vav1 and LLPS are independent, both underscore the profound role of weak interactions in regulating cellular dynamics. This ongoing journey continues to challenge and deepen my understanding of how weak interactions orchestrate the complexity of biological systems. This personal trajectory exemplifies how pursuing seemingly focused mechanistic questions can unexpectedly reveal broader principles—here, that weak interactions are not peripheral but central architects of cellular complexity and adaptability.</div></div>","PeriodicalId":369,"journal":{"name":"Journal of Molecular Biology","volume":"438 7","pages":"Article 169680"},"PeriodicalIF":4.5,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146140774","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rising Star: G Protein-coupled Receptors (GPCRs) in Microenvironment Pharmacology and Sensory Perception Pharmacology 冉冉升起的新星:G蛋白偶联受体(gpcr)在微环境药理学和感觉知觉药理学中的应用。
IF 4.5 2区 生物学 Q1 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2026-04-01 Epub Date: 2026-02-06 DOI: 10.1016/j.jmb.2026.169679
Jia-Le Wang , Shen-Ming Huang , Nai-Kang Rong , Shu-Hua Zhou , Yi Sun , Jin-Peng Sun
Professor Jinpeng Sun has long been dedicated to pharmacological research on G protein-coupled receptors (GPCRs), achieving systematic advances in areas such as ligand–receptor recognition, drug target validation, and membrane receptor-based drug development. In 2007, he earned his Ph.D. in Molecular Pharmacology from the Albert Einstein College of Medicine, after which he conducted postdoctoral research in the laboratory of Nobel Laureate Professor Robert J. Lefkowitz at Duke University, a pioneering figure in GPCR biology. In 2011, Professor Sun established his independent research group in China, where he has since pursued in-depth investigations into GPCR pharmacology. To address key bottlenecks in GPCR drug discovery, such as the unclear pathophysiological hubs of complex diseases and the difficulty in designing selective drugs, Professor Sun’s team proposed that the dynamic and multiple interactions among ligands, receptors, and intracellular (membrane) effectors are important players in microenvironment establishment and adjustment that drive or modulate disease progresses. Based on this conceptual framework, they developed a suite of innovative methodologies, including endogenous ligand capture technology, highly sensitive multipathway GPCR activity profiling systems, and microscale force activation platforms. Using these tools, the team successfully identified membrane receptors for several critical hormones and metabolites, such as glucocorticoids, androgens, progesterone, and ceramides, resolving several long-standing questions in pharmacology. They were the first to discover the GPCR responsible for the sense of balance and elucidated the molecular mechanisms through which GPCRs sense mechanical force, odors, pruritic stimuli, and acidic or alkaline environments, substantially expanding the known functional scope of GPCR biology. Furthermore, by integrating chemical biology with signaling assays, Professor Sun’s group introduced theoretical models such as the “flute model” of functional coding of GPCR phosphorylation and “proline regions docking and sorting” for GPCR biased signaling. Exploiting AI-guided ligand design, Sun’s group developed over 20 selective lead compounds targeting the GPCRs involved in psychiatric, metabolic, cardiovascular, and aging-related disorders. Several candidates have completed preliminary pharmacokinetic and toxicity studies, demonstrating strong translational potential. This article systematically summarizes the key scientific contributions from Professor Sun Jinpeng’s laboratory over the past decade, highlighting their impact on receptor-ligand paring, signaling mechanism elucidation, tool development, and rational drug design, and discusses their implications for the future of precision medicine.
孙金鹏教授长期致力于G蛋白偶联受体(gpcr)的药理学研究,在配体受体识别、药物靶点验证、基于膜受体的药物开发等领域取得了系统的进展。2007年,他在爱因斯坦医学院获得分子药理学博士学位,之后在杜克大学GPCR生物学先驱、诺贝尔奖获得者Robert J. Lefkowitz教授的实验室进行博士后研究。2011年,孙教授在中国成立了自己的独立研究小组,开始对GPCR药理学进行深入研究。为了解决GPCR药物发现的关键瓶颈,例如复杂疾病的病理生理中心不清楚以及设计选择性药物的困难,孙教授的团队提出配体,受体和细胞内(膜)效应物之间的动态和多重相互作用是驱动或调节疾病进展的微环境建立的重要参与者。基于这一概念框架,他们开发了一套创新的方法,包括内源性配体捕获技术、高灵敏度多途径GPCR活性分析系统和微尺度生物物理激活平台。利用这些工具,研究小组成功地鉴定了几种关键激素和代谢物的膜受体,如糖皮质激素、雄激素、黄体酮和神经酰胺,解决了药理学中几个长期存在的问题。他们首次发现了负责平衡感的GPCR,并阐明了GPCR感知机械力、气味、瘙痒刺激和酸性或碱性环境的分子机制,极大地扩展了GPCR生物学已知的功能范围。此外,孙教授的团队将化学生物学与信号分析相结合,引入了GPCR磷酸化功能编码的“长笛模型”和GPCR偏向信号的“脯氨酸区域对接和分选”等理论模型。利用人工智能引导的配体设计,孙的团队开发了20多种选择性先导化合物,靶向与精神、代谢、心血管和衰老相关疾病有关的gpcr。一些候选药物已经完成了初步的药代动力学和毒性研究,显示出强大的转化潜力。本文系统总结了孙金鹏教授实验室近十年来在受体配体配对、信号机制阐明、工具开发、合理药物设计等方面的重要科学贡献,并探讨了其对未来精准医学的启示。
{"title":"Rising Star: G Protein-coupled Receptors (GPCRs) in Microenvironment Pharmacology and Sensory Perception Pharmacology","authors":"Jia-Le Wang ,&nbsp;Shen-Ming Huang ,&nbsp;Nai-Kang Rong ,&nbsp;Shu-Hua Zhou ,&nbsp;Yi Sun ,&nbsp;Jin-Peng Sun","doi":"10.1016/j.jmb.2026.169679","DOIUrl":"10.1016/j.jmb.2026.169679","url":null,"abstract":"<div><div>Professor Jinpeng Sun has long been dedicated to pharmacological research on G protein-coupled receptors (GPCRs), achieving systematic advances in areas such as ligand–receptor recognition, drug target validation, and membrane receptor-based drug development. In 2007, he earned his Ph.D. in Molecular Pharmacology from the Albert Einstein College of Medicine, after which he conducted postdoctoral research in the laboratory of Nobel Laureate Professor Robert J. Lefkowitz at Duke University, a pioneering figure in GPCR biology. In 2011, Professor Sun established his independent research group in China, where he has since pursued in-depth investigations into GPCR pharmacology. To address key bottlenecks in GPCR drug discovery, such as the unclear pathophysiological hubs of complex diseases and the difficulty in designing selective drugs, Professor Sun’s team proposed that the dynamic and multiple interactions among ligands, receptors, and intracellular (membrane) effectors are important players in microenvironment establishment and adjustment that drive or modulate disease progresses. Based on this conceptual framework, they developed a suite of innovative methodologies, including endogenous ligand capture technology, highly sensitive multipathway GPCR activity profiling systems, and microscale force activation platforms. Using these tools, the team successfully identified membrane receptors for several critical hormones and metabolites, such as glucocorticoids, androgens, progesterone, and ceramides, resolving several long-standing questions in pharmacology. They were the first to discover the GPCR responsible for the sense of balance and elucidated the molecular mechanisms through which GPCRs sense mechanical force, odors, pruritic stimuli, and acidic or alkaline environments, substantially expanding the known functional scope of GPCR biology. Furthermore, by integrating chemical biology with signaling assays, Professor Sun’s group introduced theoretical models such as the “flute model” of functional coding of GPCR phosphorylation and “proline regions docking and sorting” for GPCR biased signaling. Exploiting AI-guided ligand design, Sun’s group developed over 20 selective lead compounds targeting the GPCRs involved in psychiatric, metabolic, cardiovascular, and aging-related disorders. Several candidates have completed preliminary pharmacokinetic and toxicity studies, demonstrating strong translational potential. This article systematically summarizes the key scientific contributions from Professor Sun Jinpeng’s laboratory over the past decade, highlighting their impact on receptor-ligand paring, signaling mechanism elucidation, tool development, and rational drug design, and discusses their implications for the future of precision medicine.</div></div>","PeriodicalId":369,"journal":{"name":"Journal of Molecular Biology","volume":"438 7","pages":"Article 169679"},"PeriodicalIF":4.5,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146140691","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Molecular Biology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1